Australia markets close in 3 hours 41 minutes

MicroPort CardioFlow Medtech Corporation (2160.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
1.100-0.020 (-1.79%)
As of 10:14AM HKT. Market open.
Currency in HKD

Valuation measures4

Market cap (intra-day) 2.70B
Enterprise value 1.63B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)7.29
Price/book (mrq)1.07
Enterprise value/revenue 4.84
Enterprise value/EBITDA -4.22

Trading information

Stock price history

Beta (5Y monthly) 0.38
52-week change 3-51.93%
S&P500 52-week change 321.33%
52-week high 32.490
52-week low 30.850
50-day moving average 31.129
200-day moving average 31.569

Share statistics

Avg vol (3-month) 34.13M
Avg vol (10-day) 35.44M
Shares outstanding 52.41B
Implied shares outstanding 62.41B
Float 81.11B
% held by insiders 158.59%
% held by institutions 13.90%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -140.25%
Operating margin (ttm)-139.52%

Management effectiveness

Return on assets (ttm)-9.00%
Return on equity (ttm)-18.53%

Income statement

Revenue (ttm)336.22M
Revenue per share (ttm)0.14
Quarterly revenue growth (yoy)26.60%
Gross profit (ttm)N/A
EBITDA -377.29M
Net income avi to common (ttm)-471.53M
Diluted EPS (ttm)-0.220
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.78B
Total cash per share (mrq)0.74
Total debt (mrq)70.48M
Total debt/equity (mrq)3.02%
Current ratio (mrq)10.55
Book value per share (mrq)0.97

Cash flow statement

Operating cash flow (ttm)-206.98M
Levered free cash flow (ttm)-251.67M